Daniel Chiu

483 total citations
11 papers, 319 citations indexed

About

Daniel Chiu is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Daniel Chiu has authored 11 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pediatrics, Perinatology and Child Health and 2 papers in Genetics. Recurrent topics in Daniel Chiu's work include Neonatal Health and Biochemistry (3 papers), Aldose Reductase and Taurine (2 papers) and Glioma Diagnosis and Treatment (2 papers). Daniel Chiu is often cited by papers focused on Neonatal Health and Biochemistry (3 papers), Aldose Reductase and Taurine (2 papers) and Glioma Diagnosis and Treatment (2 papers). Daniel Chiu collaborates with scholars based in United States, Taiwan and Poland. Daniel Chiu's co-authors include Alvin C. Chan, Ching K. Chow, Ching‐Ping Tseng, Ju-Chien Cheng, Arnold Stern, Chien‐Ling Huang, Ching-Hui Huang, Chin‐Hsiao Tseng, Szecheng J. Lo and Shy-Shin Chang and has published in prestigious journals such as PLoS ONE, FEBS Letters and Clinical Chemistry.

In The Last Decade

Daniel Chiu

11 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Chiu United States 7 125 66 62 50 40 11 319
Yew Koon Lim Singapore 8 205 1.6× 59 0.9× 90 1.5× 31 0.6× 110 2.8× 12 500
M. Alebouyeh Iran 10 162 1.3× 104 1.6× 70 1.1× 85 1.7× 32 0.8× 27 412
Emóke Nagy Hungary 6 167 1.3× 30 0.5× 24 0.4× 42 0.8× 61 1.5× 7 362
Samuel Wyllie United States 8 129 1.0× 45 0.7× 13 0.2× 58 1.2× 33 0.8× 11 578
Susan Warner United States 8 243 1.9× 63 1.0× 58 0.9× 124 2.5× 59 1.5× 9 624
Michele Kiernan United Kingdom 10 123 1.0× 15 0.2× 54 0.9× 41 0.8× 79 2.0× 18 310
Jae Goo Seol South Korea 9 180 1.4× 22 0.3× 19 0.3× 58 1.2× 25 0.6× 14 380
Leila Kohan Iran 14 209 1.7× 17 0.3× 36 0.6× 20 0.4× 45 1.1× 41 497
Toshiki Matsuura Japan 12 71 0.6× 21 0.3× 67 1.1× 23 0.5× 32 0.8× 32 347
Laura Tronci Italy 11 189 1.5× 22 0.3× 19 0.3× 29 0.6× 37 0.9× 19 429

Countries citing papers authored by Daniel Chiu

Since Specialization
Citations

This map shows the geographic impact of Daniel Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Chiu more than expected).

Fields of papers citing papers by Daniel Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Chiu. The network helps show where Daniel Chiu may publish in the future.

Co-authorship network of co-authors of Daniel Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Chiu. A scholar is included among the top collaborators of Daniel Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Chiu. Daniel Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chiu, Daniel, Jingjing Qi, Tin Htwe Thin, et al.. (2023). A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma. Cancer Research Communications. 3(1). 130–139. 19 indexed citations
2.
Hormigo, Adı́lia, Daniel Chiu, Mary Hahn, et al.. (2021). CTIM-09. PHASE I STUDY OF PD-L1 INHIBITION WITH AVELUMAB AND LASER INTERSTITIAL THERMAL THERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA. Neuro-Oncology. 23(Supplement_6). vi51–vi51. 3 indexed citations
3.
Chiu, Daniel & Jesse Weinberger. (2020). Cerebral Venous Sinus Thrombosis and Acute Myocardial Infarction in a Patient with PAI-1 4G/4G Homozygosity. Journal of Stroke and Cerebrovascular Diseases. 29(11). 105250–105250. 1 indexed citations
5.
Wu, Yi‐Hsuan, et al.. (2016). Diminished COX-2/PGE2-Mediated Antiviral Response Due to Impaired NOX/MAPK Signaling in G6PD-Knockdown Lung Epithelial Cells. PLoS ONE. 11(4). e0153462–e0153462. 20 indexed citations
6.
Tseng, Ching‐Ping, Chien‐Ling Huang, Kowit‐Yu Chong, Iou‐Jih Hung, & Daniel Chiu. (2005). Rapid detection of glucose-6-phosphate dehydrogenase gene mutations by denaturing high-performance liquid chromatography. Clinical Biochemistry. 38(11). 973–980. 17 indexed citations
7.
Tseng, Ching‐Ping, Chien‐Ling Huang, Ching-Hui Huang, et al.. (2003). Disabled‐2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. FEBS Letters. 541(1-3). 21–27. 61 indexed citations
8.
Tseng, Ching‐Ping, et al.. (2003). Broad-Range Ribosomal RNA Real-Time PCR after Removal of DNA from Reagents: Melting Profiles for Clinically Important Bacteria. Clinical Chemistry. 49(2). 306–309. 31 indexed citations
9.
Chan, Alvin C., Ching K. Chow, & Daniel Chiu. (1999). Interaction of Antioxidants and Their Implication in Genetic Anemia. Proceedings of The Society for Experimental Biology and Medicine. 222(3). 274–282. 125 indexed citations
10.
Cheng, Hung-Chi, et al.. (1996). Purification and characterization of endogenous digoxin-like immunoreactive factors in chicken blood. Life Sciences. 59(19). 1617–1629. 4 indexed citations
11.
Zuo, Li, et al.. (1992). A new mutation responsible for severe G6PD deficiency in two ethnic Chinese with different clinical presentations: determination by a direct PCR sequencing technique.. PubMed. 55(1). 39–44. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026